Sulcardine administration for treatment of acute atrial fibrillation
US11813245B2 · kind B2 · utility
0Cited by
8References
45Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 11, 2021 |
| Grant date | Nov 14, 2023 |
| Priority date | — |
| Expiry date | Jul 7, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compositions and methods for administration of sulcardine to a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.